Compare STBA & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STBA | PRGO |
|---|---|---|
| Founded | 1902 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | 8100 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 1995 | 2013 |
| Metric | STBA | PRGO |
|---|---|---|
| Price | $44.97 | $11.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $43.00 | $19.33 |
| AVG Volume (30 Days) | 239.3K | ★ 2.2M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | 3.29% | ★ 10.28% |
| EPS Growth | ★ 2.35 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $10.20 | N/A |
| Revenue Next Year | $4.14 | $1.02 |
| P/E Ratio | $47.87 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.01 | $9.23 |
| 52 Week High | $45.17 | $28.44 |
| Indicator | STBA | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 61.34 | 48.94 |
| Support Level | $42.25 | $10.46 |
| Resistance Level | N/A | $12.36 |
| Average True Range (ATR) | 0.81 | 0.49 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 88.18 | 30.34 |
S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.